OXTR and Atypical behavior: Since its original cloning and characterization by Kimura et al. (1992), to more recent predictions of its three dimensional structure (Busnelli et al., 2016), the human oxytocin receptor (OXTR) has garnered special attention for its role as a potential therapeutic target in a wide array of physiological and behavioral disorders.